An Australian vote for pharma: best-selling drugs
This article was originally published in Scrip
Executive Summary
The Australian pharma market reached sales of $9.1 billion in 2009, 6.4% higher than the year before. We examine which drugs accounted for these sales, and the impact the impending patent cliff will have on the market.